Shopping Cart
Remove All
Your shopping cart is currently empty
SR10221 is a noncovalent inverse agonist of PPARγ that represses downstream PPARγ target gene expression, leading to growth inhibition in bladder cancer cell lines, SR10221 is extensively utilized to explore PPARγ-driven transcriptional programs, metabolic regulation, and the therapeutic potential of inverse agonism in oncology research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | SR10221 is a noncovalent inverse agonist of PPARγ that represses downstream PPARγ target gene expression, leading to growth inhibition in bladder cancer cell lines, SR10221 is extensively utilized to explore PPARγ-driven transcriptional programs, metabolic regulation, and the therapeutic potential of inverse agonism in oncology research. |
| Synonyms | SR-10221, SR 10221 |
| Molecular Weight | 561.11 |
| Formula | C33H37ClN2O4 |
| Cas No. | 1415321-64-0 |
| Smiles | C(N1C=2C(=CC(C(N[C@@H](C)C3=CC=C(C(C)(C)C)C=C3)=O)=CC2)C(C)=C1C)C4=CC(O[C@H](C(O)=O)C)=C(Cl)C=C4 |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (178.22 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.